Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9. Lv Z, Liu L, You J, Zhou P, et al. J Med Virol 2024;96:e29894.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lv Z, Liu L, You J, Zhou P, et al. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429-dependent m6A modification of CCR9. J Med Virol 2024;96:e29894.
PMID: 39206838